Loading…

Plasma Platelet-derived Microparticles in Patients with Connective Tissue Diseases

To clarify the role of platelet-derived microparticles (PDMP), which are small vesicles with thrombotic and immunological properties, in systemic lupus erythematosus (SLE), systemic sclerosis (SSc), dermatomyositis/polymyositis (PM/DM), and mixed connective tissue disease (MCTD). Plasma levels of PD...

Full description

Saved in:
Bibliographic Details
Published in:Journal of rheumatology 2011-04, Vol.38 (4), p.680-684
Main Authors: OYABU, Chinami, MORINOBU, Akio, SUGIYAMA, Daisuke, SAEGUSA, Jun, TANAKA, Shino, MORINOBU, Sahoko, TSUJI, Goh, KASAGI, Shimpei, KAWANO, Seiji, KUMAGAI, Shunichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To clarify the role of platelet-derived microparticles (PDMP), which are small vesicles with thrombotic and immunological properties, in systemic lupus erythematosus (SLE), systemic sclerosis (SSc), dermatomyositis/polymyositis (PM/DM), and mixed connective tissue disease (MCTD). Plasma levels of PDMP were measured by ELISA, and compared among patients with one of the 4 diseases. Association of PDMP levels with clinical characteristics and medication of the patients was also examined. PDMP levels were higher in patients with MCTD and SSc than in controls. Multiple linear regression analysis revealed that patients with Raynaud's phenomenon (RP) showed higher PDMP levels than those without. PDMP levels in individual patients did not fluctuate significantly over several months. PDMP level is associated with MCTD, SSc, and RP, and could be a novel marker for RP.
ISSN:0315-162X
1499-2752
DOI:10.3899/jrheum.100780